Starpharma after 22 years, page-29

I'm jack of all this negativity, based on what? - no reputable evidence. To compare Starpharma and Viralytics is nonsense as they are totally chalk and cheese ... Starpharma is on a whole other level with its milestones, DEP technology platform and development pipeline, and products/revenues.

The lack of news is playing on some minds (with some allegedly even selling their holdings of late) which I totally understand if true - it is frustrating but again welcome to biotech - the long game. Remember DEP is the holy grail and gotta be worth a lot if all goes to plan.

According to the company there are discussions happening regarding licencing. Hello, isn't that a BIG positive? A potential MAJOR catalyst is lurking - is it 2022 or 2023? No one knows BUT it is closer than ever in SPL's history. The value being built behind the scenes should put us very soon into the big boys/girls club with a billion dollar plus capitalisation.

DYOR
IMHO
GLTAH